Clinical Trials Browser

Interventional × Uterine Cervical Neoplasms × pazopanib × Clear all

NCT01392352 2020-02-13

HYPAZ

Phase 2 Terminated

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT02348398 2016-08-16

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT00430781 2015-05-08

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Phase 2 Completed

228 enrolled 21 charts

Uterine Cervical Neoplasms, Neoplasms, Recurrence